
Please try another search
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; and CAP-2003, and allogeneic cardiosphere-derived cells-exosomes, which is in preclinical trial to treat DMD. It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
Barry J. Byrne | - | - | Member of Scientific Advisory Board |
Thomas Voit | - | - | Member of Scientific Advisory Board |
Frank Isaac Litvack | 69 | 2012 | Executive Chairman of the Board |
Linda Marbán | 62 | 2010 | Co-Founder, President, CEO & Director |
George W. Dunbar | 78 | 2013 | Independent Director |
David Brian Musket | 67 | 2013 | Independent Director |
Francesco Muntoni | - | - | Member of Scientific Advisory Board |
Michelle Eagle | - | - | Member of Scientific Advisory Board |
Craig McDonald | - | - | Member of Scientific Advisory Board |
Pat Furlong | - | - | Member of Scientific Advisory Board |
Eugenio Mercuri | - | - | Member of Scientific Advisory Board |
Karimah Es Sabar | 67 | 2021 | Independent Director |
Michael Taylor | - | 2018 | Member of Scientific Advisory Board |
Oscar Henry Mayer | - | - | Member of Scientific Advisory Board |
Philip J. Gotwals | 62 | 2023 | Independent Director |
Paul Gisbert Auwaerter | 63 | 2023 | Independent Director |
Michael Kelliher | 48 | 2023 | Independent Director |
Timothy R. Franson | 73 | 2023 | Member of the Scientific Advisory Board |
Suzanne Hendrix | - | 2023 | Member of Scientific Advisory Board |
Chet Villa | - | 2023 | Member of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review